Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir- containing regimens

Antonella Castagna, Laura Galli, Nicola Gianotti, Carlo Torti, Andrea Antinori, Renato Maserati, Antonella D'Arminio Monforte, Eugenia Quiros-Roldan, Stefania Salpietro, Adriano Lazzarin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Switches from lopinavir/ritonavir (LPV/r) to either atazanavir/ritonavir (ATV/r) or unboosted ATV (ATV) are increasingly common in clinical practice, but data on outcome comparison between these two simplification strategies are very limited. Methods. Multicenter, observational, retrospective study. Data were collected from five Italian clinics. The objective of the study was to investigate the utcome of LPV/r simplification with ATV/r or ATV and to identify factors predicting virological rebound. Patients who switched from LPV/r to ATV/r or ATV with an HIV-RNA value30000 copies/mL (28% vs 6%, p=0.014). Replacing lopinavir/r with ATV or ATV/r yielded similar rates of virological rebound. Viral load at the initiation of lopinavir/r may be useful in driving the choice between ATV/r and ATV.

Original languageEnglish
Pages (from-to)239-249
Number of pages11
JournalNew Microbiologica
Volume36
Issue number3
Publication statusPublished - Jul 2013

Fingerprint

Lopinavir
Ritonavir
Atazanavir Sulfate
Viral Load
Observational Studies
Retrospective Studies
HIV
RNA

Keywords

  • Atazanavir
  • Lopinavir
  • Ritonavir
  • Simplification
  • Unboosted

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir- containing regimens. / Castagna, Antonella; Galli, Laura; Gianotti, Nicola; Torti, Carlo; Antinori, Andrea; Maserati, Renato; D'Arminio Monforte, Antonella; Quiros-Roldan, Eugenia; Salpietro, Stefania; Lazzarin, Adriano.

In: New Microbiologica, Vol. 36, No. 3, 07.2013, p. 239-249.

Research output: Contribution to journalArticle

Castagna, A, Galli, L, Gianotti, N, Torti, C, Antinori, A, Maserati, R, D'Arminio Monforte, A, Quiros-Roldan, E, Salpietro, S & Lazzarin, A 2013, 'Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir- containing regimens', New Microbiologica, vol. 36, no. 3, pp. 239-249.
Castagna, Antonella ; Galli, Laura ; Gianotti, Nicola ; Torti, Carlo ; Antinori, Andrea ; Maserati, Renato ; D'Arminio Monforte, Antonella ; Quiros-Roldan, Eugenia ; Salpietro, Stefania ; Lazzarin, Adriano. / Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir- containing regimens. In: New Microbiologica. 2013 ; Vol. 36, No. 3. pp. 239-249.
@article{ab649d91a2e446ffa1d8dd303d7a0d68,
title = "Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir- containing regimens",
abstract = "Switches from lopinavir/ritonavir (LPV/r) to either atazanavir/ritonavir (ATV/r) or unboosted ATV (ATV) are increasingly common in clinical practice, but data on outcome comparison between these two simplification strategies are very limited. Methods. Multicenter, observational, retrospective study. Data were collected from five Italian clinics. The objective of the study was to investigate the utcome of LPV/r simplification with ATV/r or ATV and to identify factors predicting virological rebound. Patients who switched from LPV/r to ATV/r or ATV with an HIV-RNA value30000 copies/mL (28{\%} vs 6{\%}, p=0.014). Replacing lopinavir/r with ATV or ATV/r yielded similar rates of virological rebound. Viral load at the initiation of lopinavir/r may be useful in driving the choice between ATV/r and ATV.",
keywords = "Atazanavir, Lopinavir, Ritonavir, Simplification, Unboosted",
author = "Antonella Castagna and Laura Galli and Nicola Gianotti and Carlo Torti and Andrea Antinori and Renato Maserati and {D'Arminio Monforte}, Antonella and Eugenia Quiros-Roldan and Stefania Salpietro and Adriano Lazzarin",
year = "2013",
month = "7",
language = "English",
volume = "36",
pages = "239--249",
journal = "New Microbiologica",
issn = "1121-7138",
publisher = "Luigi Ponzio e figlio Editori",
number = "3",

}

TY - JOUR

T1 - Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir- containing regimens

AU - Castagna, Antonella

AU - Galli, Laura

AU - Gianotti, Nicola

AU - Torti, Carlo

AU - Antinori, Andrea

AU - Maserati, Renato

AU - D'Arminio Monforte, Antonella

AU - Quiros-Roldan, Eugenia

AU - Salpietro, Stefania

AU - Lazzarin, Adriano

PY - 2013/7

Y1 - 2013/7

N2 - Switches from lopinavir/ritonavir (LPV/r) to either atazanavir/ritonavir (ATV/r) or unboosted ATV (ATV) are increasingly common in clinical practice, but data on outcome comparison between these two simplification strategies are very limited. Methods. Multicenter, observational, retrospective study. Data were collected from five Italian clinics. The objective of the study was to investigate the utcome of LPV/r simplification with ATV/r or ATV and to identify factors predicting virological rebound. Patients who switched from LPV/r to ATV/r or ATV with an HIV-RNA value30000 copies/mL (28% vs 6%, p=0.014). Replacing lopinavir/r with ATV or ATV/r yielded similar rates of virological rebound. Viral load at the initiation of lopinavir/r may be useful in driving the choice between ATV/r and ATV.

AB - Switches from lopinavir/ritonavir (LPV/r) to either atazanavir/ritonavir (ATV/r) or unboosted ATV (ATV) are increasingly common in clinical practice, but data on outcome comparison between these two simplification strategies are very limited. Methods. Multicenter, observational, retrospective study. Data were collected from five Italian clinics. The objective of the study was to investigate the utcome of LPV/r simplification with ATV/r or ATV and to identify factors predicting virological rebound. Patients who switched from LPV/r to ATV/r or ATV with an HIV-RNA value30000 copies/mL (28% vs 6%, p=0.014). Replacing lopinavir/r with ATV or ATV/r yielded similar rates of virological rebound. Viral load at the initiation of lopinavir/r may be useful in driving the choice between ATV/r and ATV.

KW - Atazanavir

KW - Lopinavir

KW - Ritonavir

KW - Simplification

KW - Unboosted

UR - http://www.scopus.com/inward/record.url?scp=84883190842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883190842&partnerID=8YFLogxK

M3 - Article

C2 - 23912865

AN - SCOPUS:84883190842

VL - 36

SP - 239

EP - 249

JO - New Microbiologica

JF - New Microbiologica

SN - 1121-7138

IS - 3

ER -